Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of British Columbia
$27,000.00
Multimodal Profiling of Brain-Gut-Blood Interactions Underlying Domain-Specific Cognitive Impairment in Parkinson’s Disease
FY 2025-26
Summary
Parkinson’s disease is best known for movement symptoms like tremors, stiffness, and slowed motion, but many people also experience subtle changes in thinking and memory. This early stage, called mild cognitive impairment in Parkinson’s disease (PD-MCI), does not stop people from managing daily life, but it can signal who is more likely to develop dementia. PD-MCI varies widely with some individuals struggling with memory, others with attention, planning, language, or visual skills. Given the potential to slow or modify future decline, PD-MCI represents a key opportunity for advancing our understanding and treatment of cognitive impairment. Our study will explore PD-MCI by examining links between the brain, gut, and blood. Prior research shows that people with PD-MCI may have thinning in certain brain regions, bodywide inflammation, and changes in the gut microbiome, but few studies have combined these factors or connected them to specific types of cognitive problems. We will recruit people with Parkinson’s disease who have no cognitive impairment, those with PD-MCI, and healthy controls. Participants will complete tests of memory, attention, language, and problem-solving. Brain scans to assess structural degeneration, blood samples to measure inflammation, and stool samples to profile gut bacteria will be collected and then compared with participant cognitive scores. By integrating these measures, we aim to identify early biological markers linked to specific cognitive difficulties. This pilot project will show whether these combined assessments are practical and informative. If successful, it will allow for larger studies to identify who is at highest risk for dementia and to point toward new targets for early treatment.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
572923
Name
Pressman-Cyna Kyler B
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Multimodal Profiling of Brain-Gut-Blood Interactions Underlying Domain-Specific Cognitive Impairment in Parkinson’s Disease
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Blood Biomarkers; Brain–Gut Axis; Diffusion Tensor Imaging; Enzyme-Linked Immunosorbent Assays; Gut Microbiome; Metabolomics; Mild Cognitive Impairment; Neuroimaging; Neuroscience; Parkinson’S Disease
Abstract
Parkinson’s disease is best known for movement symptoms like tremors, stiffness, and slowed motion, but many people also experience subtle changes in thinking and memory. This early stage, called mild cognitive impairment in Parkinson’s disease (PD-MCI), does not stop people from managing daily life, but it can signal who is more likely to develop dementia. PD-MCI varies widely with some individuals struggling with memory, others with attention, planning, language, or visual skills. Given the potential to slow or modify future decline, PD-MCI represents a key opportunity for advancing our understanding and treatment of cognitive impairment. Our study will explore PD-MCI by examining links between the brain, gut, and blood. Prior research shows that people with PD-MCI may have thinning in certain brain regions, bodywide inflammation, and changes in the gut microbiome, but few studies have combined these factors or connected them to specific types of cognitive problems. We will recruit people with Parkinson’s disease who have no cognitive impairment, those with PD-MCI, and healthy controls. Participants will complete tests of memory, attention, language, and problem-solving. Brain scans to assess structural degeneration, blood samples to measure inflammation, and stool samples to profile gut bacteria will be collected and then compared with participant cognitive scores. By integrating these measures, we aim to identify early biological markers linked to specific cognitive difficulties. This pilot project will show whether these combined assessments are practical and informative. If successful, it will allow for larger studies to identify who is at highest risk for dementia and to point toward new targets for early treatment.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Pressman-Cyna, Kyler B
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~